TriangleNCT02761187 · OUTCOME
Number of Participants With Co-morbidities
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- Measure
- COUNT_OF_PARTICIPANTS
- Unit
- Participants
- Interval / dispersion
- Not reported
- Time frame
- Baseline up to 5 years
What was measured
Charlson Comorbidity Index (CCI) was used to represent number of participants with co-morbidities. CCI is a method of categorizing comorbidities of participants. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a participant. A score of 0 = no comorbidities found, 1 = not ill, 2 = mildly ill, 3 = moderately ill, 4 = severely ill, and ≥5 = moribund. The higher the score, the more likely the predicted outcome resulted in mortality or higher resource use.
Analysis population: All Enrolled Population included all participants who signed the inform consent form. Overall number of participants analyzed is the number of participants available for analysis.
Groups in this outcome
NDMM
Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
RRMM
Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
| Group | Source count |
|---|---|
| NDMM | 1761 |
| RRMM | 1440 |
Reported measurements
0-1
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 1279 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 1064 | Not reported | Not reported | Not reported | Not reported |
2-3
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 307 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 247 | Not reported | Not reported | Not reported | Not reported |
4-5
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 66 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 60 | Not reported | Not reported | Not reported | Not reported |
>5
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 38 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 19 | Not reported | Not reported | Not reported | Not reported |
Missing
| Group | Value | Spread | Lower | Upper | Comment |
|---|---|---|---|---|---|
| NDMM | 71 | Not reported | Not reported | Not reported | Not reported |
| RRMM | 50 | Not reported | Not reported | Not reported | Not reported |
Complete source fields
- calculate Pct
- false
- classes
- categories
- measurements
- group Id
- OG000
- value
- 1279
- group Id
- OG001
- value
- 1064
- title
- 0-1
- categories
- measurements
- group Id
- OG000
- value
- 307
- group Id
- OG001
- value
- 247
- title
- 2-3
- categories
- measurements
- group Id
- OG000
- value
- 66
- group Id
- OG001
- value
- 60
- title
- 4-5
- categories
- measurements
- group Id
- OG000
- value
- 38
- group Id
- OG001
- value
- 19
- title
- >5
- categories
- measurements
- group Id
- OG000
- value
- 71
- group Id
- OG001
- value
- 50
- title
- Missing
- denoms
- counts
- group Id
- OG000
- value
- 1761
- group Id
- OG001
- value
- 1440
- units
- Participants
- description
- Charlson Comorbidity Index (CCI) was used to represent number of participants with co-morbidities. CCI is a method of categorizing comorbidities of participants. Each comorbidity category has an associated weight (from 1 to 6), based on the adjusted risk of mortality or resource use, and the sum of all the weights results in a single comorbidity score for a participant. A score of 0 = no comorbidities found, 1 = not ill, 2 = mildly ill, 3 = moderately ill, 4 = severely ill, and ≥5 = moribund. The higher the score, the more likely the predicted outcome resulted in mortality or higher resource use.
- groups
- description
- Participants newly diagnosed with MM within 3 months from initiation of treatment were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
- id
- OG000
- title
- NDMM
- description
- Participants diagnosed with RRMM who previously received 1 to 3 prior lines of therapy were enrolled for 3 years, and followed for at least 2 years, until death, or the end of the study, whichever comes first (up to approximately 5 years).
- id
- OG001
- title
- RRMM
- param Type
- COUNT_OF_PARTICIPANTS
- population Description
- All Enrolled Population included all participants who signed the inform consent form. Overall number of participants analyzed is the number of participants available for analysis.
- reporting Status
- POSTED
- time Frame
- Baseline up to 5 years
- title
- Number of Participants With Co-morbidities
- type
- PRIMARY
- unit Of Measure
- Participants
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice